Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Matrix Metalloproteinase-14 Expression and Its Prognostic Value in Cervical Carcinoma.

Wang H, Zhang X, Huang L, Li J, Qu S, Pan F.

Cell Biochem Biophys. 2014 May 1. [Epub ahead of print]

PMID:
24789545
[PubMed - as supplied by publisher]
2.

Prognostic significance of α5β1-integrin expression in cervical cancer.

Wang HY, Chen Z, Wang ZH, Wang H, Huang LM.

Asian Pac J Cancer Prev. 2013;14(6):3891-5.

PMID:
23886203
[PubMed - indexed for MEDLINE]
Free Article
3.
4.

ADAM17 is associated with EMMPRIN and predicts poor prognosis in patients with uterine cervical carcinoma.

Xu Q, Ying M, Chen G, Lin A, Xie Y, Ohara N, Zhou D.

Tumour Biol. 2014 Aug;35(8):7575-86. doi: 10.1007/s13277-014-1990-1. Epub 2014 May 4.

PMID:
24793016
[PubMed - in process]
5.

Increased expression of α5β1-integrin is a prognostic marker for patients with gastric cancer.

Ren J, Xu S, Guo D, Zhang J, Liu S.

Clin Transl Oncol. 2014 Jul;16(7):668-74. doi: 10.1007/s12094-013-1133-y. Epub 2013 Nov 19.

PMID:
24248895
[PubMed - in process]
6.

Clinical significance of matrix metalloproteinase-2 in cancer of uterine cervix: a semiquantitative study of immunoreactivities using tissue array.

Wang PH, Ko JL, Tsai HT, Yang SF, Han CP, Lin LY, Chen GD.

Gynecol Oncol. 2008 Mar;108(3):533-42. doi: 10.1016/j.ygyno.2007.11.018. Epub 2008 Jan 4.

PMID:
18177928
[PubMed - indexed for MEDLINE]
7.

Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis.

Katayama A, Bandoh N, Kishibe K, Takahara M, Ogino T, Nonaka S, Harabuchi Y.

Clin Cancer Res. 2004 Jan 15;10(2):634-40.

PMID:
14760086
[PubMed - indexed for MEDLINE]
Free Article
8.

Clinicopathological and prognostic significance of α5β1-integrin and MMP-14 expressions in colorectal cancer.

Yang B, Gao J, Rao Z, Shen Q.

Neoplasma. 2013;60(3):254-61. doi: 10.4149/neo_2013_034.

PMID:
23373994
[PubMed - indexed for MEDLINE]
10.

[Relationship between the expression of matrix metalloproteinase-13 protein and other biomarkers, prognosis in invasive breast cancer].

Zhang B, Liu YX, Cao WF, Cao XC, Ning LS, Hao XS.

Zhonghua Bing Li Xue Za Zhi. 2008 Jul;37(7):471-6. Chinese.

PMID:
19035119
[PubMed - indexed for MEDLINE]
11.

Matrix metalloproteinase-9 is a prognostic marker for patients with cervical cancer.

Li Y, Wu T, Zhang B, Yao Y, Yin G.

Med Oncol. 2012 Dec;29(5):3394-9. doi: 10.1007/s12032-012-0283-z. Epub 2012 Jun 30.

PMID:
22752570
[PubMed - indexed for MEDLINE]
12.

Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.

Pellikainen JM, Ropponen KM, Kataja VV, Kellokoski JK, Eskelinen MJ, Kosma VM.

Clin Cancer Res. 2004 Nov 15;10(22):7621-8.

PMID:
15569994
[PubMed - indexed for MEDLINE]
Free Article
13.

Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis.

Zheng HC, Takahashi H, Murai Y, Cui ZG, Nomoto K, Miwa S, Tsuneyama K, Takano Y.

Br J Cancer. 2006 Nov 20;95(10):1371-8. Epub 2006 Oct 31.

PMID:
17088917
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

[Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix].

Zhou CY, Yao JF, Chen XD.

Ai Zheng. 2002 Jul;21(7):735-9. Chinese.

PMID:
12479097
[PubMed - indexed for MEDLINE]
15.

Matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor (TIMP-2) are prognostic factors in cervical cancer, related to invasive disease but not to high-risk human papillomavirus (HPV) or virus persistence after treatment of CIN.

Branca M, Ciotti M, Giorgi C, Santini D, Di Bonito L, Costa S, Benedetto A, Bonifacio D, Di Bonito P, Paba P, Accardi L, Syrjänen S, Favalli C, Syrjänen K; HPV-PathogenISS Study Group.

Anticancer Res. 2006 Mar-Apr;26(2B):1543-56.

PMID:
16619570
[PubMed - indexed for MEDLINE]
Free Article
16.

[Expression and clinical significance of MMP-2, MMP-9,TIMP-1, and TIMP-2 in breast carcinoma].

Fan SQ, Wei QY, Li MR, Zhang LQ, Liang QC.

Ai Zheng. 2003 Sep;22(9):968-73. Chinese.

PMID:
12969531
[PubMed - indexed for MEDLINE]
17.

Prognostic value of matrix metalloproteinase-1/ proteinase-activated receptor-1 signaling axis in hepatocellular carcinoma.

Liao M, Tong P, Zhao J, Zhang Y, Li Z, Wang J, Feng X, Hu M, Pan Y.

Pathol Oncol Res. 2012 Apr;18(2):397-403. doi: 10.1007/s12253-011-9458-8. Epub 2011 Sep 10.

PMID:
21909684
[PubMed - indexed for MEDLINE]
18.

[Expression of COX-2 and MMP-9 in cervical carcinoma and their clinical significance].

Luo CF, Zhu RQ, Wang H, Lu YL.

Zhonghua Zhong Liu Za Zhi. 2007 Jul;29(7):526-30. Chinese.

PMID:
18069634
[PubMed - indexed for MEDLINE]
19.

[Significance of expression of chemokine receptor and matrix metalloproteinase in small cell lung cancer].

Li RJ, Zhao LJ, Zhan ZL, Lü X, Gong LL, Wang P.

Zhonghua Yi Xue Za Zhi. 2012 Feb 28;92(8):532-5. Chinese.

PMID:
22490156
[PubMed - indexed for MEDLINE]
20.

[The expression of matrix metalloproteinase-2 and -9 in cervical cancer and a study of their relationship].

Ouyang YW, Peng ZL, Yao XY, Liu SL, He YD.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2004 May;35(3):330-3. Chinese.

PMID:
15181827
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk